NR3C2 and essential hypertension: Yagi et al. found that individuals with primary hypertension and relatively high—though normal—aldosterone levels had reduced cognitive performance on the MMSE which significantly improved after six months of MR antagonist therapy, suggesting a possible link between aldosterone and cognitive function [9].